Literature DB >> 24046056

Osteoporosis and sarcopenia: the connections.

Umberto Tarantino1, Jacopo Baldi, Monica Celi, Cecilia Rao, Federico Maria Liuni, Riccardo Iundusi, Elena Gasbarra.   

Abstract

Osteoporosis and sarcopenia are the most frequent musculoskeletal disorders affecting older people. Osteoporosis is a widespread disorder affecting millions of individuals of all ethnic backgrounds worldwide, particularly among older women. It is characterized by reduced bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in the risk of fracture. Sarcopenia is considered to be one of the major factors responsible for functional limitations and motor dependency in elderly persons. In age-related muscle atrophy, a decrease in muscle fiber size and number, and a preferential loss of type II fibers have been reported. A decrease in the circulating levels of specific hormones (e.g., estrogen, testosterone, growth hormone, and insulin-like growth factor-1) has been shown to be associated with sarcopenia and this appears to play an important role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24046056     DOI: 10.1007/s40520-013-0097-7

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  26 in total

1.  Vitamin D Deficiency and Molecular Changes in Circulating MicroRNAs in Older Adults with Lower Back Pain.

Authors:  Hadeel A Al-Rawaf; Sami A Gabr; Ahmad H Alghadir
Journal:  Pain Res Manag       Date:  2021-05-17       Impact factor: 3.037

2.  The Relationship between Diet Quality and Falls Risk, Physical Function and Body Composition in Older Adults.

Authors:  D Smee; K Pumpa; M Falchi; F E Lithander
Journal:  J Nutr Health Aging       Date:  2015-12       Impact factor: 4.075

3.  Effect of a home-based resistance exercise program in elderly participants with osteoporosis: a randomized controlled trial.

Authors:  F Zhang; Z Wang; H Su; H Zhao; W Lu; W Zhou; H Zhang
Journal:  Osteoporos Int       Date:  2022-06-15       Impact factor: 5.071

4.  The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging.

Authors:  Alexandra M V Wennberg; Clinton E Hagen; Mary M Machulda; John H Hollman; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Michelle M Mielke
Journal:  Neurobiol Aging       Date:  2018-02-19       Impact factor: 4.673

5.  Body Composition, IGF1 Status, and Physical Functionality in Nonagenarians: Implications for Osteosarcopenia.

Authors:  Eleonora Poggiogalle; Katie E Cherry; L Joseph Su; Sangkyu Kim; Leann Myers; David A Welsh; S Michal Jazwinski; Eric Ravussin
Journal:  J Am Med Dir Assoc       Date:  2018-08-24       Impact factor: 4.669

Review 6.  Algodystrophy in major orthopaedic surgery.

Authors:  Umberto Tarantino; Rodrigo Buharaja; Eleonora Piccirilli; Mariastella Riccardi; Elena Gasbarra; Maurizio Feola; Giovanni Iolascon
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

7.  Bone Mineral Density and Fatty Degeneration of Thigh Muscles Measured by Computed Tomography in Hip Fracture Patients.

Authors:  Myung Hoon Hahn; Ye-Yeon Won
Journal:  J Bone Metab       Date:  2016-11-30

Review 8.  Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach.

Authors:  Antonino Catalano; Gabriella Martino; Nunziata Morabito; Claudia Scarcella; Agostino Gaudio; Giorgio Basile; Antonino Lasco
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

9.  Association of sitting time and breaks in sitting with muscle mass, strength, function, and inflammation in community-dwelling older adults.

Authors:  N Reid; G N Healy; J Gianoudis; M Formica; P A Gardiner; E E Eakin; C A Nowson; R M Daly
Journal:  Osteoporos Int       Date:  2018-02-26       Impact factor: 4.507

Review 10.  Metabolic Bone Diseases and New Drug Developments.

Authors:  Vijayakumar Natesan; Sung-Jin Kim
Journal:  Biomol Ther (Seoul)       Date:  2022-03-28       Impact factor: 4.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.